Purpose: Elderly patients with multiple primary or oligometastases (<5 lesions) lesions with associated co-morbidities may not retain their treatment position for the traditional long SBRT treatment time with individual isocenters for each lesion.
| INTRODUCTION
With recent technological advances, SBRT treatment to solitary primary or metastatic lung lesions for medically inoperable non-smallcell lung cancer (NSCLC) patients is safe, effective and has a high cure rate comparable to surgery. [1] [2] [3] [4] SBRT can be beneficial for elderly patients. 5 However, elderly patients who developed multiple primary or oligometastases (<5 lesions) lung lesions with associated co-morbidities may not retain their treatment position for traditional long SBRT treatment times with an individual isocenter placed for each lesion. Treating multiple lung lesions synchronously with a single-isocenter plan, either using intensity-modulated radiation therapy (IMRT) or volumetric arc therapy (VMAT), has been studied by a few researchers. [6] [7] [8] [9] Furthermore, utilizing flattening filter free (FFF) beam 10 for single-isocenter multiple-lesion VMAT lung stereotactic body radiation therapy (SBRT) treatment was fast and efficient, improved the patient comfort and is gaining popularity in clinical practice. [11] [12] [13] Recently, Varian Eclipse treatment planning system (TPS, Varian Medical Systems, Palo Alto CA, Version 13.6) has implemented a new multi leaf collimators (MLC) optimization algorithm, called photon optimizer (PO). Photon optimizer was created to be more efficient for IMRT/VMAT optimization over its predecessor, progressive resolution optimizer (PRO). 14 The main difference between PO and PRO algorithms is that PO uses a new structure model. For PO, the structures, dose-volume histogram calculations and dose sampling are defined spatially using a single matrix over the image instead of a point-cloud model defining structures that was used in the PRO algorithm. In this configuration, PO algorithm under-samples voxels at the periphery of the target. However, PO configuration uses multiresolution dose calculation approach to increase the dose calculation accuracy. Fixed voxel resolutions of 1.25, 2.5 or 5 mm can be used during multiresolution optimization. For a single-lesion treatment, a few investigators have reported dosimetric differences between PO and PRO optimization for IMRT/VMAT plans. [15] [16] [17] [18] For instance, the advantages and limitations of PO algorithm compared to its predecessor PRO for IMRT plans were evaluated by Binny et al. 16 Eleven plans including prostate, brain, and head and neck treatments were optimized using both PO and PRO algorithms. For similar target coverage and dose to critical structures, they reported that PO algorithm gave higher MLC variability and more monitor units. However, Liu et al. 18 compared PO with PRO algorithms for VMAT planning of lung SBRT and brain stereotactic treatments.
Their retrospective study included 20 lung SBRT patients (10 received 54 Gy in 3 fractions and 10 received 50 Gy in 5 fractions) and 10 brain stereotactic patients received 25 Gy in five fractions.
For identical target coverage, PO algorithm provided comparable plan quality to PRO, with less MLC complexity, thus improving the treatment delivery and contradicting Binny et al. 16 Although dosimetric differences with PO algorithm for a singlelesion treatment with SBRT have been studied previously by Liu et al. 18 , the dosimetric impact and treatment delivery complexity of this algorithm with a FFF-beam in the treatment of multiple lesions simultaneously using a single-isocenter VMAT lung SBRT plan has not yet been reported. When using a single-isocenter for VMAT lung SBRT, the MLCs must travel a longer distance to provide adequate coverage to each lesion simultaneously. Moreover, due to under sampling of the voxels at the periphery of each tumor by the PO algorithm, this distance could cause higher nontarget normal tissue dose to the organs-at-risk (OAR) adjacent to the tumor. This prompted us to quantify the effect of PO MLC algorithm for our clinical implementation of single-isocenter/multi-lesions VMAT lung SBRT approach. Dose to radiosensitive nontarget OAR is a major concern in VMAT lung SBRT treatment, 19, 20 A single-isocenter was placed approximately between/among the tumors in each patient. Average isocenter to tumors distance was 5.6 ± 1.9 cm. Highly conformal, clinically optimal VMAT treatment plans were generated on the free-breathing CT scan using 2-6 co/ non-coplanar full/partial arcs (5°-10°, couch kicks were used for noncoplanar partial arcs) for the Truebeam linear accelerator (Varian, Palo Alto, CA) with millennium MLC and a 6MV-FFF (1400MU/min) beam. All clinical plans were optimized in Eclipse (version 13.6) with PO algorithm using a fixed 2.5 mm voxel resolution. The standard millennium 120 leaves with 5 mm leaf width were used for treatment planning and delivery. For 6X-FFF beam, MLC transmission and leakage modeled in Eclipse was 1.5% in addition to 1.1 mm dosimetric leaf gap. PO sparsely samples a point dose cloud model for defining structures and spatial dose using one single matrix over the image. For each arc, collimator angles were chosen such that the opening of the MLC between/among tumors was minimized for each patient. Additionally, the jaw tracking option was chosen during VMAT plan optimization to further minimize the non-target dose.
Advanced Acuros-based dose calculation and dose to medium was used. A dose of 54 or 50 Gy in 3 and 5 fractions was prescribed to 70%-80% isodose line such that at least 95% of the each PTV received the prescription dose. In addition to optimization ring structures, the generalized normal tissue objective (NTO) parameters were used to control the gradients for each target. Planning objectives for the OAR were per RTOG 0915 guidelines. 3 The main tumor characteristics of the patients included in this study is shown in Table 2 ). However, the total number of MU, MF, and BOT show statistically significant differences between the two plans (see Table 2 ). PO algorithm pro- Table 2 ). Most importantly, the beam-on time was improved by
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The isodose distribution is shown for photon optimizer (PO) (left) and progressive resolution optimizer (PRO) (right) for an example case patient who was treated for bilateral lung lesions, synchronously using 2-full co-planner arcs. This patient received a synchronous SBRT treatment to a total dose of 50 Gy to each lesion in 5 fractions. The single-isocenter location is shown by the cross-hair. Tumors were located in bilateral lungs. Isocenter to tumor distance was an average of 5.8 cm. Combined planning target volume (PTV) was 24.5 cc with lesion 1, PTV1 (left lung) = 18.0 cc and lesion 2, PTV2 (right lung) = 6.5 cc. PO and PRO algorithms provided similar SBRT dose distributions to each lung lesion. SBRT setting (see Fig. 4 ).
A few investigators have reported the dosimetric differences in PO algorithm for IMRT/VMAT planning in a digital phantom, 15 conventional prostate, head and neck, and brain treatments, 16 knowledge-based planning to rectal cancer patients 17 and a single-lesion lung SBRT and stereotactic brain treatments. 18 The PO-MLC plans reduced the total number of MU significantly and hence increased the treatment delivery efficiency compared to its predecessor PRO algorithm. Furthermore, MF increases as a function of isocenter to tumors distance (see right panel), suggesting that the farther apart the tumors are, but for similar target(s) coverage, there is significantly less beam-modulation with PO compared to PRO-MLC algorithm.
MLC openings is important for improving delivery accuracy, especially with the MLC leaves traveling relatively longer distances between tumors in the synchronous treatments presented here.
Even though PO under sampled voxels at the periphery of each tumor, the dosimetric differences were insignificant to the OAR with similar VMAT QA results and improvement of delivery efficiency.
In summary, the potential benefit of PO algorithm on Truebeam 
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